
Jiangsu GTIG Huatai Co., Ltd. is one of China's top 500 companies, specializing in intermediates and APIs for Sofosbuvir, Ledipasvir, Velpatasvir, Venetoclax, Obeticholic Acid, Palbociclib, Glecaprevir, Dolutegravir, Alectinib, Eribulin Mesylate, Bictegravir, Niraparib, Ribociclib, Dabigatran etexilate mesylate, Sacubitril, Vilanterol, Umeclidinium Bromide, Indacaterol, Ibrutinib, Baricitinib and Pazopanib, among others, with any patent-related products supplied for research purposes only.

Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen